Stryker Corp (SYK)
337.15
+0.30
(+0.09%)
USD |
NYSE |
Apr 25, 16:00
337.15
0.00 (0.00%)
Pre-Market: 08:26
Stryker Free Cash Flow: 3.136B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.136B |
| September 30, 2023 | 2.568B |
| June 30, 2023 | 2.417B |
| March 31, 2023 | 2.267B |
| December 31, 2022 | 2.036B |
| September 30, 2022 | 2.015B |
| June 30, 2022 | 2.067B |
| March 31, 2022 | 2.453B |
| December 31, 2021 | 2.738B |
| September 30, 2021 | 3.016B |
| June 30, 2021 | 2.973B |
| March 31, 2021 | 2.712B |
| December 31, 2020 | 2.79B |
| September 30, 2020 | 2.254B |
| June 30, 2020 | 1.96B |
| March 31, 2020 | 1.798B |
| December 31, 2019 | 1.542B |
| September 30, 2019 | 1.898B |
| June 30, 2019 | 1.91B |
| March 31, 2019 | 2.053B |
| December 31, 2018 | 2.038B |
| September 30, 2018 | 1.639B |
| June 30, 2018 | 1.098B |
| March 31, 2018 | 1.125B |
| December 31, 2017 | 961.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 983.00M |
| June 30, 2017 | 1.43B |
| March 31, 2017 | 1.29B |
| December 31, 2016 | 1.425B |
| September 30, 2016 | 1.584B |
| June 30, 2016 | 614.00M |
| March 31, 2016 | 524.00M |
| December 31, 2015 | 711.00M |
| September 30, 2015 | 655.00M |
| June 30, 2015 | 1.717B |
| March 31, 2015 | 1.744B |
| December 31, 2014 | 1.549B |
| September 30, 2014 | 1.547B |
| June 30, 2014 | 1.65B |
| March 31, 2014 | 1.643B |
| December 31, 2013 | 1.691B |
| September 30, 2013 | 1.622B |
| June 30, 2013 | 1.554B |
| March 31, 2013 | 1.651B |
| December 31, 2012 | 1.447B |
| September 30, 2012 | 1.463B |
| June 30, 2012 | 1.341B |
| March 31, 2012 | 1.042B |
| December 31, 2011 | 1.208B |
| September 30, 2011 | 1.107B |
Free Cash Flow Range, Past 5 Years
1.542B
Minimum
Dec 2019
3.136B
Maximum
Dec 2023
2.345B
Average
2.267B
Median
Mar 2023
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.703B |
| Haemonetics Corp | 128.75M |
| Abbott Laboratories | 5.059B |
| Zimmer Biomet Holdings Inc | 1.204B |
| Edwards Lifesciences Corp | 629.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.528B |
| Cash from Investing (Quarterly) | -152.00M |
| Cash from Financing (Quarterly) | -286.00M |
| Free Cash Flow Per Share (Quarterly) | 3.604 |
| Free Cash Flow to Equity (Quarterly) | 1.078B |
| Free Cash Flow to Firm (Quarterly) | 1.383B |
| Free Cash Flow Yield | 2.42% |